Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Evaluation of Fisetin to Reduce Systemic Senescence Indices: A Randomized Controlled Dosing Equivalence Study
Authors not listed
Steadman Philippon Research Institute · 2023
Abstract
This is a prospective, randomized clinical trial to evaluate the ability of the supplement, Fisetin, to safely reduce systemic senescence(definition) (aging) indices assessed in peripheral blood.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2023). Evaluation of Fisetin to Reduce Systemic Senescence Indices: A Randomized Controlled Dosing Equivalence Study. <em>Steadman Philippon Research Institute</em>. https://clinicaltrials.gov/study/NCT07918261
Vancouver
Anonymous. Evaluation of Fisetin to Reduce Systemic Senescence Indices: A Randomized Controlled Dosing Equivalence Study. Steadman Philippon Research Institute. 2023.
BibTeX
@misc{anon2023Evalua,
title = {Evaluation of Fisetin to Reduce Systemic Senescence Indices: A Randomized Controlled Dosing Equivalence Study},
author = {Anonymous},
journal = {Steadman Philippon Research Institute},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bundang CHA Hospital 2015
Open access · US-GOV
A Randomized, Double-blinded and Placebo-controlled Pilot Clinical Trial to Evaluate the Potential Efficacy and Safety of Human Umbilical Cord Blood and Plasma by Clinical Markers of Frailty in Adult Who Defined Pre-Frailty
ENCell 2027
Open access · US-GOV
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Clinical Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Sarcopenia
Standard Process Inc. 2025
Open access · US-GOV
The Effect of Nutritional Supplementation on Actinic Purpura: A Pilot Study
Journal of Dermatological Science 2009
Citation only
DNA damage responses in skin biology—Implications in tumor prevention and aging acceleration
Daehwa Pharmaceutical Co., Ltd. 2016
Open access · US-GOV
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase IIb, Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2021
Open access · US-GOV